Multicomponent Intervention to Improve Hypertension Control in Central America

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1854 participants.

Also called NCT03504124

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,854 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03504124
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Guatemala (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03504124. Randomized; no masking; primary purpose treatment. Start 2019-07-17 (actual); primary completion 2022-04-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multicomponent Intervention to Improve Hypertension Control in Central America
Condition
Arterial Hypertension
Intervention (Other)
Multicomponent intervention
Lead sponsor
Institute of Nutrition of Central America and Panama (class: other)
Collaborator
Tulane University School of Public Health and Tropical Medicine (class: other)
Collaborator
Institute for Clinical Effectiveness and Health Policy (class: other)
Collaborator
Colorado School of Public Health (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct03504124
Content hash
882aa6fb4b29626588c6d7791edcf5b759b7e32fcd248ede6ad0581fb8ab035f